Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 1/2011

01.01.2011 | Miscellaneous

Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary

verfasst von: Adebukola Adebayo, Jignesh G. Parikh, Steven A. McCormick, Mahendra K. Shah, Remedios S. Huerto, Guopei Yu, Tatyana Milman

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Bacterial conjunctivitis is one of the most common forms of ocular diseases worldwide. The purpose of this study is to determine the most common pathogens causing bacterial conjunctivitis, their in vitro susceptibility to existing antibiotics, and the changing trends in bacterial resistance to antibiotics over the last decade.

Methods

Records of all conjunctival bacterial cultures performed at the NYEEI Microbiology Laboratory from 1 January 1997 through 30 June 2008 were reviewed. Data on species of bacterial isolates and their in vitro susceptibility to the antibiotics tetracycline, trimethaprim/sulfamethoxazole (TMP/SMZ), imipenem, fluoroquinolones (ciprofloxacin, moxifloxacin, gatifloxacin), aminoglycosides (gentamicin, tobramycin), erythromycin, cefazolin, oxacillin, and vancomycin were collected.

Results

Review of records yielded 20,180 conjunctival bacterial cultures, 60.1% of which were culture-positive. Of the culture-positive isolates, 76.6% were gram-positive and 23.4% were gram-negative pathogens. Staphylococcus aureus was the most common gram-positive pathogen isolated, and also the most commonly isolated pathogen overall. Haemophilus influenzae was the most common gram-negative pathogen. A significant increase in the percentage of methicillin-resistant Staphylococcus aureus (MRSA) was observed in the course of 11.5 years. The highest levels of antibiotic resistance were observed to tetracycline, erythromycin, and TMP/SMZ. Gram-positive isolates were least resistant to vancomycin, and gram-negative isolates were least resistant to imipenem. The lowest broad-spectrum antibiotic resistance was observed in the case of moxifloxacin, gatifloxacin, and aminoglycosides.

Conclusion

Staphylococcus aureus is the most common pathogen in bacterial conjunctivitis. Conjunctival bacterial isolates demonstrated high levels of resistance to tetracycline, erythromycin and TMP/SMZ. Moxifloxacin and gatifloxacin appear to be currently the best choice for empirical broad-spectrum coverage. Vancomycin is the best antibiotic for MRSA coverage.
Literatur
1.
Zurück zum Zitat McDonnell PJ (1988) How do general practitioners manage eye diseases in the community? Br J Ophthalmol 72:733–736CrossRefPubMed McDonnell PJ (1988) How do general practitioners manage eye diseases in the community? Br J Ophthalmol 72:733–736CrossRefPubMed
3.
Zurück zum Zitat Ostler HB (1993) Conjunctival infections and inflammations. In: Ostler HB (ed) Diseases of the External Eye and Adnexa: A Text and Atlas. Williams & Wilkins, Baltimore, pp 67–136 Ostler HB (1993) Conjunctival infections and inflammations. In: Ostler HB (ed) Diseases of the External Eye and Adnexa: A Text and Atlas. Williams & Wilkins, Baltimore, pp 67–136
4.
Zurück zum Zitat Tarabishy AB, Jeng BH (2008) Bacterial conjunctivitis: a review for internists. Cleve Clin J Med 75(7):507–512CrossRef Tarabishy AB, Jeng BH (2008) Bacterial conjunctivitis: a review for internists. Cleve Clin J Med 75(7):507–512CrossRef
5.
Zurück zum Zitat Morrow GL, Abbott RL (1998) Conjunctivitis. Am Fam Physician 57:528–529 Morrow GL, Abbott RL (1998) Conjunctivitis. Am Fam Physician 57:528–529
6.
Zurück zum Zitat Sheikh A, Hurwitz B (2008) Bacterial conjunctivitis. In: Roy FH, Fraunfelder FW, Fraunfelder FT (eds) Roy and Fraunfelder’s Current Ocular Therapy, 6th edn. Elsevier, Philadelphia, pp 332–334 Sheikh A, Hurwitz B (2008) Bacterial conjunctivitis. In: Roy FH, Fraunfelder FW, Fraunfelder FT (eds) Roy and Fraunfelder’s Current Ocular Therapy, 6th edn. Elsevier, Philadelphia, pp 332–334
7.
Zurück zum Zitat Leibowitz HM (1991) Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Am J Ophthalmol 112(4):29–33 Leibowitz HM (1991) Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Am J Ophthalmol 112(4):29–33
8.
Zurück zum Zitat Gigliotti F, Hendley JO, Morgan J, Michaels R, Dickens M, Lohr J (1984) Efficacy of topical antibiotic therapy in acute conjunctivitis in children. J Pediatr 104(4):623–626CrossRefPubMed Gigliotti F, Hendley JO, Morgan J, Michaels R, Dickens M, Lohr J (1984) Efficacy of topical antibiotic therapy in acute conjunctivitis in children. J Pediatr 104(4):623–626CrossRefPubMed
9.
Zurück zum Zitat Jensen HG, Felix C, In Vitro Antibiotic Testing Group (1998) In vitro antibiotic susceptibilities of ocular isolates in North and South America. Cornea 17(1):79–87CrossRefPubMed Jensen HG, Felix C, In Vitro Antibiotic Testing Group (1998) In vitro antibiotic susceptibilities of ocular isolates in North and South America. Cornea 17(1):79–87CrossRefPubMed
10.
Zurück zum Zitat Alvarenga LS, Ginsberg B, Mannis MJ (2008) Bacterial conjunctivitis. In: Tasman W, Jaeger EA (eds) Duane’s Clinical Ophthalmology. Vol 4. Lippincott, Williams & Wilkins, Philadelphia, pp 1–17 Alvarenga LS, Ginsberg B, Mannis MJ (2008) Bacterial conjunctivitis. In: Tasman W, Jaeger EA (eds) Duane’s Clinical Ophthalmology. Vol 4. Lippincott, Williams & Wilkins, Philadelphia, pp 1–17
11.
Zurück zum Zitat Chalita MR, Hofling-Lima AL, Paranhos A Jr, Schor P, Belfort R Jr (2004) Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years. Am J Ophthalmol 137:43–51CrossRefPubMed Chalita MR, Hofling-Lima AL, Paranhos A Jr, Schor P, Belfort R Jr (2004) Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years. Am J Ophthalmol 137:43–51CrossRefPubMed
12.
Zurück zum Zitat Cavuoto K, Zutshi D, Karp CL, Miller D, Feuer W (2008) Update on bacterial conjunctivitis in South Florida. Ophthalmology 115(1):51–56CrossRefPubMed Cavuoto K, Zutshi D, Karp CL, Miller D, Feuer W (2008) Update on bacterial conjunctivitis in South Florida. Ophthalmology 115(1):51–56CrossRefPubMed
13.
Zurück zum Zitat Alexandrakis G, Alfonso EC, Miller D (2000) Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones. Ophthalmology 107(8):1497–1502CrossRefPubMed Alexandrakis G, Alfonso EC, Miller D (2000) Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones. Ophthalmology 107(8):1497–1502CrossRefPubMed
14.
Zurück zum Zitat Suh DW (2008) Escherichia coli. In: Roy FH, Fraunfelder FW, Fraunfelder FT (eds) Roy and Fraunfelder’s Current Ocular Therapy, 6th edn. Elsevier, Philadelphia, pp 28–29 Suh DW (2008) Escherichia coli. In: Roy FH, Fraunfelder FW, Fraunfelder FT (eds) Roy and Fraunfelder’s Current Ocular Therapy, 6th edn. Elsevier, Philadelphia, pp 28–29
15.
Zurück zum Zitat Jansen HG, Perry HD, Donnenfeld ED (2008) Antibacterials. In: Albert D, Miller J, Azar D, Blodi B (eds) Albert & Jakobiec’s Principles and Practice of Ophthalmology, vol 1, 3rd edn. Elsevier, Philadelphia, pp 207–214 Jansen HG, Perry HD, Donnenfeld ED (2008) Antibacterials. In: Albert D, Miller J, Azar D, Blodi B (eds) Albert & Jakobiec’s Principles and Practice of Ophthalmology, vol 1, 3rd edn. Elsevier, Philadelphia, pp 207–214
16.
Zurück zum Zitat to hereGarat M, Moser CL, Alonso-Tarres C, Martin-Baranera M, Alberdi A (2005) Intracameral cefazolin to prevent endophthalmitis in cataract surgery: 3-year retrospective study. J Cataract Refract Surg 31(11):2230–2234CrossRefPubMed to hereGarat M, Moser CL, Alonso-Tarres C, Martin-Baranera M, Alberdi A (2005) Intracameral cefazolin to prevent endophthalmitis in cataract surgery: 3-year retrospective study. J Cataract Refract Surg 31(11):2230–2234CrossRefPubMed
17.
Zurück zum Zitat Asbell PA, Sahm DF, Shaw M, Draghi DC, Brown NP (2008) Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005. J Cataract Refract Surg 34(5):814–818CrossRefPubMed Asbell PA, Sahm DF, Shaw M, Draghi DC, Brown NP (2008) Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005. J Cataract Refract Surg 34(5):814–818CrossRefPubMed
18.
Zurück zum Zitat Hautala N, Koskela M, Hautala T (2008) Major age group-specific differences in conjunctival bacteria and evolution of antimicrobial resistance revealed by laboratory data surveillance. Curr Eye Res 33(11):907–911CrossRefPubMed Hautala N, Koskela M, Hautala T (2008) Major age group-specific differences in conjunctival bacteria and evolution of antimicrobial resistance revealed by laboratory data surveillance. Curr Eye Res 33(11):907–911CrossRefPubMed
19.
Zurück zum Zitat Freidlin J, Acharya N, Lietman TM, Cevallos V, Whitcher JP, Margolis TP (2007) Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am J Ophthalmol 144(2):313–315CrossRefPubMed Freidlin J, Acharya N, Lietman TM, Cevallos V, Whitcher JP, Margolis TP (2007) Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am J Ophthalmol 144(2):313–315CrossRefPubMed
20.
Zurück zum Zitat Sakoulas G, Moellering RC Jr (2008) Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis 46(S5):S360–S367CrossRefPubMed Sakoulas G, Moellering RC Jr (2008) Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis 46(S5):S360–S367CrossRefPubMed
21.
Zurück zum Zitat Baum J, Barza M (2000) The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis: 1970–2000. Cornea 19(5):659–672CrossRefPubMed Baum J, Barza M (2000) The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis: 1970–2000. Cornea 19(5):659–672CrossRefPubMed
22.
Zurück zum Zitat Block SL, Hedrick J, Tyler R et al (2000) Increasing bacterial resistance in pediatric acute conjunctivitis (1997–1998). Antimicrob Agents Chemother 44:1650–1654CrossRefPubMed Block SL, Hedrick J, Tyler R et al (2000) Increasing bacterial resistance in pediatric acute conjunctivitis (1997–1998). Antimicrob Agents Chemother 44:1650–1654CrossRefPubMed
23.
Zurück zum Zitat Sheikh A, Hurwitz B (2005) Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review and meta-analysis update. Br J Gen Pract 55:962–964PubMed Sheikh A, Hurwitz B (2005) Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review and meta-analysis update. Br J Gen Pract 55:962–964PubMed
Metadaten
Titel
Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary
verfasst von
Adebukola Adebayo
Jignesh G. Parikh
Steven A. McCormick
Mahendra K. Shah
Remedios S. Huerto
Guopei Yu
Tatyana Milman
Publikationsdatum
01.01.2011
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 1/2011
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-010-1426-6

Weitere Artikel der Ausgabe 1/2011

Graefe's Archive for Clinical and Experimental Ophthalmology 1/2011 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.